The interplay of dysglycemia and dyslipidemia: Managing CV burden in individuals with CV risk

Asociación Europea para el Estudio de la Diabetes (EASD)

Sesión en el congreso del EASD 2019 dentro del marco del simposio 'The interplay of dysglycemia and dyslipidemia: Managing CV burden in individuals with CV risk':

'Welcome and introductions' - Prof. Luis Masana

'Urgency in treating dyslipidaemias in individuals with diabetes and high CV risk' / Urgencia en el tratamiento de la dislipidemia en personas con diabetes y alto riesgo cardiovascular  - Prof. Helen Colhoun

'Individuals with diabetes and high risk CV who may benefit the most from PCSK9 inhibition in your clinical practice' - Prof. Luis Masana

'Evaluating the benefit/risk and safety of PCSK9 inhibitors: implications in clinical practice' - Asst. Prof. Ann Marie Navar

Q&A panel discussion

Conclusion and takeaways

Temas relacionados

    Más sobre ciencia

    Contenido recomendado